Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
Figure 5
FCM analysis of cellular uptake of Apt-NPs and NPs by MCF-7 (left) and HepG2 cells (right).
The cells were incubated with FITC encapsulated Apt-NPs or NPs at 50 µg/ml for 2 hours before subject to analysis.